Increased levels of nitrite in the sera of children infected with human immunodeficiency virus type 1

Clinical Infectious Diseases

Volumn 22, Issue 4, 1996, Pages 650-653

  Torre, Donato ^a,b   Ferrario, Giulio ^a   Speranza, Filippo ^a   Martegani, Roberto ^a   Zeroli, Claudia ^a  

^a OSPEDALE DI CIRCOLO   (Italy)

^b Azienda Ospedaliero universitaria di Varese   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHILD; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SEROLOGY;

EID: 0029799946     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.4.650     Document Type: Article

References (19)

1. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-6.
2. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
3. Marletta MA. Nitric oxide: biosynthesis and biological significance. Trends Biochem Sci 1989;14:488-92.
4. Green SJ, Nacy CA, Meltzer MS. Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J Leukocyte Biol 1991;50:93-103.
5. Adams LB, Hibbs JB Jr, Taintor RR, Krahenbuhl JL. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii: role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol 1990;144:2725-9.
6. Flesch IEA, Kaufmann SHE. Mechanisms involved in mycobacterial growth inhibition by interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect Immun 1991;59:3213-8.
7. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-64.
8. Croen KD. Evidence for an antiviral effect of nitric oxide. Inhibition of herpes simplex type 1 replication. J Clin Invest 1993;91:2446-52.
9. Jorens PG, Van Overveld FJ, Vermeire PA, Bult H, Herman AG. Synergism between interleukin-1β and interferon-γ, an inducer of nitric oxide synthase, in rat lung fibroblasts. Eur J Pharmacol 1992;224:7-12.
10. Lamas S, Michel T, Brenner BM, Marsden PA. Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-α. Am J Physiol 1991;261(4):C634-41.
11. Barnes PJ, Belvisi MG. Nitric oxide and lung disease. Thorax 1993;48:1034-43.
12. Zheng YM, Schäfer MKH, Weihe E, et al. Severity of neurological size and degree of inflammatory lesions in the brain of rats with borna disease correlate with the induction of nitric oxide synthase. J Virol 1993;67:5786-91.
13. Hayman M, Arbuthnott G, Harkiss G, et al. Neurotoxicity of peptide analogues of the transactivating protein tat from maedi-visna virus and human immunodeficiency virus. Neuroscience 1993;53:1-6.
14. Pietraforte D, Tritarelli E, Testa U, Minetti M. gp 120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J Leukocyte Biol 1994;55:175-82.
15. Torre D, Ferrario G, Bonetta G, Zeroli C, Giola M, Fiori GP. The role of nitric oxide in patients with HIV-1 infection [abstract no 114]. In: Program and abstracts of the 10th International Conference on AIDS and STDs (Yokohama, Japan). 1994.
16. Torre D, Ferrario G, Bonetta G, Speranza F, Zeroli C. Production of nitric oxide from peripheral blood mononuclear cells and polymorphonuclear leukocytes of patients with HIV-1 infection [letter]. AIDS 1995;9: 979-80.
17. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Study Group. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. N Engl J Med 1991;325:73-80.
18. Dwyer JM. Manipulating the immune system with immune globulin. N Engl J Med 1992;326:107-11.
19. Rosen FS. Putative mechanisms of the effect of intravenous γ-globulin. Clin Immunol Immunopathol 1993;67(suppl):S41-3.